Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1336 CNY

100%
Buy Us a Coffee

CVE-2015-3954

Quick assessment

Affected
Hospira Plum A+ Infusion System
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.

Hospira Plum A+ Infusion System、Plum A+3 Infusion System和Symbiq Infusion System都是美国赫升瑞（Hospira）公司的智能输液系统。 多款Hospira产品中存在身份验证绕过漏洞。攻击者可利用该漏洞绕过身份验证机制，执行未授权操作。以下产品及版本受到影响：Hospira Plum A+ Infusion System 13.4及之前版本，Plum A+3 Infusion System 13.6及之前版本，Symbiq Infu

AI Predicted 9.8 Difficulty: Trivial EPSS 2.04% · P80
Get alerts for future matching vulnerabilities Log in to subscribe

I. Basic Information for CVE-2015-3954

Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: CVE Program / CVE List V5
Vulnerability Description
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Source: CVE Program / CVE List V5
CVSS Information
N/A
Source: CVE Program / CVE List V5
Vulnerability Type
授权机制不恰当
Source: CVE Program / CVE List V5
Vulnerability Title
多款Hospira产品安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Hospira Plum A+ Infusion System、Plum A+3 Infusion System和Symbiq Infusion System都是美国赫升瑞（Hospira）公司的智能输液系统。 多款Hospira产品中存在身份验证绕过漏洞。攻击者可利用该漏洞绕过身份验证机制，执行未授权操作。以下产品及版本受到影响：Hospira Plum A+ Infusion System 13.4及之前版本，Plum A+3 Infusion System 13.6及之前版本，Symbiq Infu
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

Vendor Product Affected Versions CPE Subscribe
Hospira Plum A+ Infusion System <= 13.4 -
Hospira Plum A+3 Infusion System <= 13.6 -
Hospira Symbiq Infusion System <= 3.13 -

II. Public POCs for CVE-2015-3954

# POC Description Source Link Shenlong Link
AI-Generated POC Premium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2015-3954

请登录查看更多情报信息。

Vendor Advisories for CVE-2015-3954 (1)

Same Patch Batch · Hospira · 2019-03-25 · 5 CVEs total

CVE-2015-1012 Hospira Lifecare PCA Infusion Pump 信息泄露漏洞
CVE-2015-3952 多款Hospira产品信息泄露漏洞
CVE-2015-3953 多款Hospira产品安全漏洞
CVE-2015-3956 多款Hospira产品安全漏洞

IV. Related Vulnerabilities

Same product: Plum A+ Infusion System
Same vendor: Hospira
Same weakness: CWE-285

V. Comments for CVE-2015-3954

No comments yet

Leave a comment